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Background & Aims: The benefits of prophylactic clipping to prevent bleeding after polypectomy 
are unclear. We conducted an updated meta-analysis of randomized trials to assess the efficacy of 
clipping in preventing bleeding after polypectomy, overall and according to polyp size and location. 
 
Methods: We searched the Medline/PubMed, EMBASE, and Scopus databases randomized trials 
that compared effects of clipping vs not clipping to prevent bleeding after polypectomy. We 
performed a random-effects meta-analysis to generate pooled relative risks (RRs) with 95% CIs. 
Multilevel random-effects meta-regression analysis wa  used to combine data on bleeding after 
polypectomy and estimate associations between rates of bleeding and polyp characteristics. 
 
Results: We analyzed data from 9 trials, comprising 7197 colorectal lesions (22.5% 20 mm or 
larger, 49.2% with proximal location). Clipping, compared with no clipping, did not significantly 
reduce the overall risk of post-polypectomy bleeding (2.2% with clipping vs 3.3% with no clipping; 
RR, 0.69; 95% CI, 0.45–1.08; P=.072). Clipping significantly reduced risk of bleeding after 
removal of polyps that were 20 mm or larger (4.3% had bleeding after clipping vs 7.6% had 
bleeding with no clipping; RR, 0.51; 95% CI, 0.33–0.78; P=.020) or that were in a proximal 
location (3.0% had bleeding after clipping vs 6.2% had bleeding with no clipping; RR, 0.53; 95% 
CI, 0.35–0.81; P<.001). In multilevel meta-regression analysis thatadjusted for polyp size and  
location, prophylactic clipping was significantly associated with reduced risk of bleeding after 
removal of large proximal polyps (RR, 0.37; 95% CI, 0.22–0.61; P=.021) but not small proximal 
lesions (RR, 0.88; 95% CI, 0.48–1.62; P=0.581). 
 
Conclusions: In a meta-analysis of randomized trials, we found that routine use of prophylactic 
clipping does not reduce risk of post-polypectomy bleeding, overall. However, clipping appeared to 
reduce bleeding after removal of large (more than 20 mm), proximal lesions. 
 
















Colonoscopy and endoscopic resection of precancerous lesions significantly decreases the 
risk of Colorectal Cancer (CRC) incidence and death [1-3]. However, endoscopic procedures might 
result in adverse events, such as post-procedural pain, intra- or post-procedural bleeding, 
perforation and even death [4]. Post-procedural (delayed) bleeding (PPB) after polypectomy and 
endoscopic mucosal resection is the most common major adverse event, ranging from 1% to 6% 
[5,6]. Larger lesion size and proximal location arew ll-established risk factors for PPB [7,8]. PPB 
may require the need for hospitalization, blood transfusion, and further endoscopic or more invasive 
treatments, representing a risk for the patient and a burden to the health system. 
Despite lack of high quality evidence, prophylactic clipping has been advocated as a 
technique to reduce the risk of PPB. For instance, th  European Society of Gastrointestinal 
Endoscopy (ESGE) suggests that there may be a role for prophylactic clipping, and that this 
decision be based on patient risk factors [4]. However, this recommendation has been graded as 
weak since it is based on low quality evidence. Previous meta-analysis, mostly analyzing studies 
with small lesions (<20 mm) and at high risk of bias, reported no protective effect of prophylactic 
clipping for non-pedunculated lesions [9-11]. Recently, high-quality randomized controlled trials 
(RCTs) have been published, investigating the efficacy of prophylactic clipping primarily for 
lesions larger than 20 mm. However, there is uncertainty on the overall efficacy of clipping and 
whether it is possible to identify sub-groups that may benefit from prophylactic clipping. This issue 
is clinically relevant considering the costs and technical complexity of clipping.  
 
We performed a systematic review and meta-analysis of all available RCTs to clarify the 
role of prophylactic clipping in preventing post polypectomy bleeding following endoscopic 




The methods of our analysis and inclusion criteria were based on Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) recommendations [12]. Our systematic review 
protocol was registered with the International Prospective Register of Systematic Reviews 
(PROSPERO, www.crd.york.ac.uk/prospero/) on October 2019. 
The following methods are reported in appendix 1: data sources and search strategy, the selection 
process, data extraction and the quality assessment. 
 
Inclusion and exclusion criteria 
For the purpose of our meta-analysis, we screened all clinical studies for the following inclusion 
criteria:  
(I) Population: all adults undergoing endoscopic resection of colorectal lesions.  
(II)  Intervention: post-polypectomy prophylactic closure of mucosal defects with hemoclips.  
(III)  Comparison: no prophylactic clipping post-polypectomy.  
(IV)  Outcome: risk of delayed post-polypectomy bleeding.  
(V) Study design: only randomized controlled trials were considered.  
Exclusion criteria were as follows:  
(I) Essential information not available;  
(II)  Studies not published as full text article; 
(III)  Studies not published in the English language; 
(IV)  Studies considering as comparator any intervention strategy for post procedural bleeding 
prophylaxis (i.e. cauterization of post-procedural ulcer floor by argon plasma 
coagulation, injective strategies, use of topical hemostatic agents, etc). 
(V) studies including less than 10 patients in each group 
 
Study end-points 
The primary aim of this study was to assess the efficacy of endoscopic clipping for the prevention 
of PPB. We included all patients randomly assigned to the clipping group in the intention-to-treat 
(ITT) analysis. When both sets of data were provided, values from ITT were preferred to per-
protocol (PP). A per-protocol (PP) analysis was also conducted, including only those patients who 
underwent a complete closure of the mucosal defect. PPB was defined as any post procedural 
clinically evident hematochezia that required medical intervention (hospitalization, blood 
transfusion, repeated colonoscopy, angiography or surgery) or caused a more than 2 g/dL decrease 
in the blood hemoglobin concentration.  
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The secondary aim of the study was to determine the ffect of risk factors (patient and lesion) on the
risk of PPB with and without clipping. The risk factors taken into account were: patient age and 
gender, use of antiplatelet/anticoagulant therapy, s well as lesion characteristics such as the polyp 
size; morphology and location (proximal), and histology (serrated and adenomatous). Lesions 
≥20mm were defined as ‘large’ and morphology was described according to the Paris classification 
[13]. Lesion location was defined as per the reporting in the studies.  An additional secondary aim 
was to assess the efficacy of endoscopic clipping for the prevention of other post-procedural 
adverse events such as perforation.  
 
Statistical Analysis 
All statistical analyses were conducted with the R program (version 3.5.1, 2018-07-02) [14]. In 
particular, we used the meta [15] and metafor [16] libraries in R to conduct the meta-analysis and 
meta-regression analysis. All tests are two tailed. For all tests, a probability level less than .05 was 
considered significant. Study characteristics were summarized using descriptive statistics. Risk 
ratios (RR) and 95% CIs were estimated with the Mantel-Haenszel (fixed-effects model) and the 
DerSimonian-Laird (random-effects model) methods. The summary effect sizes from random-
effects meta-analysis (assumption that the effects stimated in the different studies were not 
identical) were calculated. We assessed statistical heterogeneity between studies by visual 
inspection of forest plots and by the I2 and χ2 statistics for heterogeneity. I2-values of 0-30%, 30-
60%, 50-90% and 75-100% were classified as low, moderate, substantial and considerable 
heterogeneity, respectively.  We also calculated the 95% CI for pooled estimates, as well as the 
prediction interval (PI) [17]. 
Sensitivity analyses were performed to assess the stability of the results, namely, a single study in 
this meta-analysis was omitted one at a time to assess the influence of the individual study to the 
pooled RR [18]. Visual inspection of funnel plot asymmetry was conducted along with the Egger’s 
weighted regression method to assess publication bias (P<0.05 was considered statistically 
significant).  
 
Meta-Regression Analysis of relative risk estimates and subgroup analyses 
We conducted a meta-regression analysis to investigate the impact of various risk factors on the 
study estimates of relative risk. The natural logarithm of the risk ratio was the dependent variable, 
and study level characteristics (e.g., number of participants, mean age, percentage of males, the 
percentage of proximal polyps, the percentage of large polyps) were entered as explanatory factors. 
As the first step, we performed univariate regression analyses for each factor. All significant factors 
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(at a significance level of p<0.10) were then included in a multivariable regression model. The 
estimated coefficients of the regression model corresponded to differences in the log risk ratios for 
one unit of difference in the explanatory factor (continuous variable) or for each category relative to 
the baseline category (for categorical explanatory variables). Of note, input percentages (e.g., the 
percentage of proximal polyps) were analyzed as continuous variables, expressed originally as 
decimal fractions. The percentages were multiplied by 10 before entering in the regression model. 
Therefore, a change of 1 unit on the scaled variables corresponded to a change of 0.10 (10%) in the 
original variables. Subgroup analyses were also performed according to the polyp location 
(proximal vs. distal colon) and size (large vs. small polyps). 
 
Multilevel (random-effects) model: meta-analysis of rates of PPB with clipping versus no clipping 
As a subsequent step, we performed a multilevel regression analysis to estimate the rates of PPB 
associated with clipping versus no clipping. The outc me measure in this analysis was the 
proportion of PPB transformed via logits. Since thestudies included in the analysis reported 
multiple outcome measures, we used a multilevel meta-analysis method to combine data, with 
random effects at both the study level and at the outcome level (see Appendix 1). The multilevel 
model was extended by including predictor variables (i.e., study group, prevalence of large lesions 
and proximal colon location) in an attempt to determine variables that moderate the effect. In this 
model, predictor variables were aggregated at the study-arm level. We also considered appropriate 
interactions between these variables. Data were present d as odds ratios (ORs) and 95% CIs. This 
analysis was an indirect way to deal with aspects such as the possibility of effect modification by 
polyp characteristics, and to examine for decreasing bleeding risk with clipping vs. not clipping. 
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RESULTS 
Study characteristics and quality 
The initial literature search resulted in 1112 articles (Figure 1). A total of 9 trials were included in 
the final analysis [19-27]. Study characteristics are shown in Table 1. Studies were published 
between 2003 and 2019 in USA (n=3), Europe (n=1) and Asia (n=5). Five studies involved multiple 
centers, while 4 studies were single-center experiences.  The objective assessment of the risk of bias 
is reported in Supplemental Table 1 (Appendix 2). 
The total number of participants included in the intention-to-treat analysis was 4557 (2288 in the 
clipping and 2,269 in the control group), and the individual study sample size ranged from 26 to 
1,499 patients. Mean patient age ranged from 60.5 to 72.7 years. A total of 7197 colorectal lesions 
were analyzed (3544 clip and 3653 control group). The percentage of proximal polyps ranged from 
25% to 92% with the mean percentage at 49.2%. The mean size of polyps ranged from 7.8 mm to 
37.3 mm with an average polyp size of 18.6 mm. Of the analyzed studies, 3 included only patients 
with polyps > 20 mm; 3 with patients having polyps of  any size (mean percentage of lesions ≥20
mm, 19.4%), whereas the remaining 3 studies included only lesions <20 mm in size.  
 
Effect of clipping on PPB risk  
Based on data reported by all 9 trials, the estimates of PPB risk between the control and clip groups 
were 3.3% (95% CI:1.9-5.7%) and 2.2% (95% CI:1.2-3.9%) (multilevel random-effect model 
accounting for the underlying heterogeneity between and within trials), respectively (Appendix 3. 
Supplemental Figure 1). No significant difference between the 2 groups was noted for the risk of 
PPB when a random-effects model was applied (RR= 0.69, 95% CI:0.45-1.08, p=0.072, Figure 2). 
Moderate heterogeneity among the studies existed (I2 = 31%, p=0.170), and the likelihood of 
publication bias was low (p=0.42) (Appendix 3. Supplemental Figure 2). The results of the meta-
analysis did not change substantially when data from “per-protocol” analysis were combined 
(Appendix 3. Supplemental Figure 3).  The results of the “Leave-One-Out” sensitivity analysis 
are reported in Appendix 2. Supplemental Table 2. Only one study that evaluated patients with 
lesions <20 mm  was determined to have a substantial i fluence on the overall effect size [23]. 
After removing this trial (in a sensitivity analysis) the heterogeneity was significantly reduced 
(I2=8.2%) and the pooled (random-effects) RR was 0.58 [0.39; 0.88]. To further investigate the 
impact of study level characteristics on RR estimates, we performed a meta-regression analysis 
(Table 2). The analysis showed that use of prophylactic clipping was associated with a significant 
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reduction in PPB as the percentage of large lesions in the study population increased. The meta-
regression coefficient for the percentage of large  (≥20 mm) lesions was 0.92 (95% CI: 0.85-0.98), 
indicating that for every 10% increase in the percentage of large lesions, the RR of PPB decreased 
by 8% (95% CI:2-15%) if prophylactic clipping was utilized (Appendix 3. Supplemental Figure 
4). This finding was remarkably robust in the multilevel multivariate analysis (Appendix 2. 
Supplementary Table 3).  
Effect of clipping on PPB risk according to polyp size  
A sub-group analysis by polyp size (large versus small polyps) confirmed the above meta-
regression result (Figure 3). A beneficial effect of clipping was determined among studies 
including ≥20mm polyps (RR=0.51; 95% CI:0.33-0.78), while among those with <20mm polyps, 
there was no significant benefit (RR=1.04; 95% CI:0.60-1.79). According to multilevel random-
effects meta-regression analysis, the estimated rates of PPB among ≥20mm and <20mm lesions 
were 7.6% (95% CI:4.9-11.5%) and 1.8% (95% CI:1.1-2.9%), respectively, in the control group 
compared to 4.3% (95% CI:2.5-7.1%) and 1.4% (95% CI:0.9-2.4%), respectively, in the 
prophylactic clipping group (Appendix 2. Supplemental Table 4 Appendix 3. Supplemental 
Figure 5).  Again, the multilevel model indicated showed a protective effect of clipping for large 
polyps that remained significantly after adjusting for the prevalence of proximal polyps (OR, 0.53; 
95% CI:0.31-0.90).  
Effect of clipping on PPB risk based on polyp location with sub-analysis by size. 
Seven trials with available data on proximal/distal lesions (1618/1648 clipped and 1650/1720 
control groups) were included in this analysis. Figure 4 graphs the risk ratios and 95% CIs from the 
individual trials and the pooled results. Among proximally located lesions, there was a significant 
association between use of prophylactic clipping and risk of PPB (RR=0.53; 95% CI:0.35-0.81). 
However, among distally located lesions there was no ignificant difference between the 2 groups 
and risk of PPB (RR=1.01; 95% CI: 0.43-2.37). This a sociation was corroborated by both 
sensitivity analysis among studies defining proximal lesions as those located proximal to the splenic 
flexure (including transverse colon), and those defining proximal lesions as in the cecum, ascending 
colon or hepatic flexure (Appendix 3. Supplemental Figure 6 and 7). According to a multilevel 
random-effects meta-regression analysis, the estimated r tes of PPB in the distal and proximal colon 
were 2.7% (95% CI:1.3-5.4%; PI:0.5-12.3%) and 6.2% (95% CI:3.4-11.1%; PI:1.3-24.3%), 
respectively, in the control group compared to 3.3% (95% CI:1.6-6.5%; PI:0.7-14.6%) and 3.0% 
(95% CI:1.5-5.7%; PI:0.6-13.2%), respectively, in the clip group (Appendix 3. Supplementary 
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Figure 8). The above model showed a protective effect of clipping for proximally located polyps 
(clipped proximal vs. unclipped proximal polyps, OR, 0.46; 95% CI:0.24-0.88) (Appendix 3 Table 
5).  
After adjusting for the prevalence of large lesions in the multilevel model, the benefit of clipping in 
reducing PPB was significant only for large proximal lesions (clipped versus unclipped polyps, OR, 
0.37; 95% CI:0.22-0.61; p=0.021), but not for small proximal lesions (clipped versus unclipped 
polyps, OR, 0.88; 95% CI:0.48-1.62; p=0.581). This finding was remarkably robust in sub-group 
and sensitivity analyses (Figure 5 and Appendix 3 Supplementary Figure 9). Clipping was also not 
beneficial for large distal lesions (RR:0.70; 95% CI:0.22-2.27), although this outcome mainly 
depended by the lack of benefit in only one large serie  (Appendix 3. Supplementary Figure 10), 
and for small distal lesions (RR:1.34; 95% CI:0.42-4.35; Figure 5).   
Perforations.  
Data on perforation were available in 6 studies. In total, 14 perforation events were reported 
(6/1074, 0.56% in the clip and 8/1085, 0.74% in control group) with a RR of 0.70; 95% CI:0.25-
1.91; p=0.480; I2 = 0.0%), indicating no significant differences between groups.  
 
Additional analysis 
The quality of evidence was assessed by applying the GRADE methodology. The level of evidence 
for RCTs was downgraded due to low-moderate quality of the included RCTs (assessed by 
Cochrane risk bias tool for randomized studies) andthe inconsistency owing to heterogeneity 
among patients (i.e. different indications to resection in term of lesion size or location). Details can 
be found in Appendix 2. Supplemental Table 6.  
Additional technical features such as types of clips used and electrosurgical unit characteristics are 




 According to our meta-analysis, routine practice of endoscopic clipping as a prophylactic 
intervention does not reduce the risk of post-polypectomy bleeding. However, clipping was 
effective in reducing the risk of PPB by nearly 50% for large lesions (>20 mm). If such lesions do 
not undergo endoscopic clipping, there was 4-fold increase in the baseline risk of PPB as compared 
with those <20 mm. Such benefit appeared to be limited to large lesions located in the proximal 
colon. 
The results of our analysis are relevant for several re sons. Meta-analysis of randomized 
trials is considered as the strongest evidence for clinical recommendations. The lack of efficacy of 
prophylactic clipping after any polypectomy was confirmed by our results showing no significant 
difference in PPB risk between the 2 groups (clip vs control group). This was further confirmed by 
the ‘leave-one-analysis’ – i.e. clipping became signif cantly effective when excluding this series – 
as this was the largest series on small lesions. This inference is a distinctive advantage of our 
analysis, as the previous systematic reviews were not powered enough to perform it [9-11, 30-32].  
Our analysis showed the clinical relevance of two main factors: polyp size and location, on 
both the absolute risk of PPB and the relative efficacy of clipping, as well as their hierarchical 
interaction. Our adjusted estimates attributed a nearly 2-fold increase – from 4.3% to 7.6% – in the 
risk of PPB for lesions >20 mm. This finding was supported by two additional results. First, the 
PPB risk estimate proportionally increased as the percentage of >20 mm increased in the included 
studies. Secondly, such cut-off size was the only significant risk factor associated at meta-
regression with PPB risk.  
While showing an increase in the PPB risk according to size, our data also showed a clear 
reduction in PPB risk with clipping. A 50% reduction in PPB for those with clipped >20 mm 
lesions directly translated to a NNT of 23 for lesions to be clipped in order to prevent one additional 
bleeding. A recent US-based study showed significant ost-savings when adopting such a cut-off 
[33].  
Regarding location, our data support proximal locati n as possible risk factor for PPB risk 
and clipping efficacy. In the control group we observed a 2-fold increase in the risk for PPB for 
polyps located in the distal versus the proximal colon – from 2.7% to 6.2% respectively. Regarding 
the interaction between size and location, size >20 mm appeared to be the primary determinant of 
PPB risk. Thus, the benefit of clipping was clear in large proximal lesions, while it was absent for 
small lesions, even when they were located in the proximal colon. On the other hand, the risk of 
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PPB and clipping efficacy was somewhat intermediate – albeit not statistically significant – for 
large and distal lesions. This was mainly attributed to the lack of the effect of clipping in a large 
study on >20 mm lesions [26]. However, this was not confirmed by other studies generating some 
uncertainty on the benefit of prophylactic clipping for large distal lesions. Thus, the decision for 
large and distal lesions should be tailored, especially taking into consideration other patient- and 
polyp-risk factors for PPB, such as the use of anti-thrombotic agent or intra-procedural bleeding. 
The studies included in our analysis did not reveal significant heterogeneity nor publication bias. 
This indicates that the effect is homogeneous across the different series, suggesting generalizability 
and reproducibility of the results. Of note, the only study that contributed to the slight heterogeneity 
on our primary end-point [23] included only small polyps, suggesting that such size inclusion 
criteria could explain the slight degree of heterogneity, as confirmed by subsequent meta-
regression and subgroup results. In addition, the observation that the effect is orientated towards 
clipping efficacy in the vast majority of the cases trengthens the robustness of our observation.  
Our data pair with recent cost-effectiveness analysis (using Medicare cost data and CMS 
billing codes) focusing on the impact of adoption of routine prophylactic clipping in practice from a 
payer perspective, considering relevant patient- and polyp-specific factors [33]. Considering that 
clips are expensive and their placement might be technically demanding, prophylactic clipping 
tailored for a subgroup of higher risk lesions/patients would decrease in parallel both adverse events 
and costs. Our data support the use of clipping for any large proximal lesion, excluding its use for 
those <20 mm and those located in the distal colon. On the other hand, the choice for large distal 
ones is likely to be less effective, and should be individualized according to also patient 
characteristics [34]. 
There are the limitations to our study. First of all, the paucity of data about patient’s 
comorbidities and the management of antithrombotic therapies prior to endoscopic resection in 
many of the included studies limited our ability to infer on this relevant topic. Thus, high quality 
RCTs are needed to determine whether prophylactic clips should be suggested after resecting small 
(<20 mm) and distal lesions in patients on antithromb tic therapies. Secondly, some of the included 
studies were of low to moderate quality, limiting the quality of our recommendations. Furthermore, 
study limitations such as lack of blinding of outcome assessors could almost be considered as 
intrinsic of RCTs evaluating endoscopic procedures, y t remaining the best possible evidence. Also, 
several patients included in the analysis underwent mul iple resections. In case of bleeding, it is 
sometimes difficult to determine which polypectomy site was bleeding in patients who did not 
undergo colonoscopy. Further, even in cases requiring endoscopy the bleeding site may remain 
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uncertain. Last, we were not able to stratify data according to technical variables that might affect 
the risk of bleeding (and the effect of clipping) such as hemoclips or electrosurgical unit 
characteristics (Supplemental Table 7).   
 In conclusion, the results of our meta-analysis of RCTs do not support the routine use of 
prophylactic clipping for the prevention of PPB. However, clipping appeared to be beneficial in 
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Figure 1. PRISMA flow diagram. RCTs: randomized controlled trials 
Figure 2. Forest plot comparing clipping vs. not clipping arm. The relative risk of developing a post-
(delayed) polypectomy bleeding (PPB) event for polys clipped or unclipped is displayed. The line-of-n-
effect (vertical line) separates outcomes that favor clipping and not clipping. The squared red boxes represent 
the point estimates and the horizontal lines represent the associated 95% confidence intervals for each study. 
The area of each square is proportional to the study's weight in the meta-analysis. Overlapping confidence 
intervals of the individual studies and an I2 value of 31% with a non-significant p-value (0.17) indicates 
homogeneity of the studies. Studies were separated according to size criterion for polyp inclusion: studies 
including large lesions in their datasets (i.e., with, w lesions ≥20mm) and those including only 
lesions<20mm (i.e., without, w/o ≥20mm ). 
Figure 3 - Subgroup analysis of relative risk of developing post-polypectomy (delayed) bleeding events 
(PPB) with and without clipping for large polyps versus small polyps. For each subgroup, the relative risk of 
developing PPB for polyps clipped or unclipped is di played. The line-of-no-effect (vertical line) separates 
outcomes that favor clipping and not clipping. The squared red boxes represent the point estimates and the 
horizontal lines represent the associated 95% confide ce intervals for each study. The area of each square is 
proportional to the study's weight in the meta-analysis.  Overlapping confidence intervals of the individual 
studies and I2 values with non-significant p-values indicates homogeneity of the studies.  
Figure 4 – Subgroup analysis comparing clipping vs. not clipping arm for successful control of post-
polypectomy (delayed) bleeding events (PPB) for distally and proximally located lesions. For each subgroup, 
the relative risk of developing a PPB for polyps clipped or unclipped is displayed. The line-of-no-effect 
(vertical line) separates outcomes that favor clipping and not clipping. The squared red boxes represent th  
point estimates and the horizontal lines represent the associated 95% confidence intervals for each study. The 
area of each square is proportional to the study's weight in the meta-analysis.   Overlapping confidence 
intervals of the individual studies and a I2 value with a non-significant p-value indicates homogeneity of the 
studies.  
Figure 5 – Sub-analysis of size according to location. In this analysis, results from the studies were analyzed 
according two subgroups: studies including more than 50% of large lesions in their analysis sets were 
considered “large” polyps, the others “small” polyps. The PPB risks for clipped and unclipped large and
proximal polyps were 3.8% (95% CI:2.1-6.9%) and 10.0% (95% CI:6.6-16.7%) (RR, 0.34; 95% CI:0.19-
0.65), while PPB risks for small and proximal polyps were 2.2% (95% CI:0.9-5.7%) and 4.3% (95% CI:1.1-
10.1%), respectively, (RR. 0.50; 95% CI:0.16-1.57). The corresponding features for clipped and unclipped 
large and distal polyps were 5.0% (95% CI:2.2-10.7%) and 7.0% (2.8-16.6%), respectively, (RR:0.70; 95% 
CI:0.22-2.27), while PPB risks for small and distal polyps were 2.2% (95% CI:0.8-5.6%) and 1.6% (95% 
CI:0.7-4.1%), respectively (RR:1.34; 95% CI:0.42-4.35)  
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Variable RR 95% CI P-value RR 95% CI P-value 
No. of participants  
(per 100-individual increase) 1.03 1.00-1.06 0.051 1.01 0.98-1.05 0.438 
Mean patient age, year       
<66 years 1      
>65 years 0.54 0.23-1.26 0.155    
Country       
US/Europe 1      
Asia 0.99 0.33-3.00 0.991    
Percentage of male participants  0.99 0.40-0.33 0.957    
Percentage of large lesions  0.92 0.85-0.98 0.017 0.92 0.86-0.99  0.042 
Percentage of proximal lesions  0.88 0.74-1.05 0.152    
Percentage of non-polypoid lesions  1.27 0.21-7.54 0.792    
Percentage of non-pedunculated 
lesions  0.14 0.01-4.21 0.256    
Percentage of adenomatous lesions 1.10 0.78-1.52 0.680    
Percentage of serrated lesions  0.11 0.00-5.72 0.276    
Percentage of patients with 








Data sources and search strategy 
We performed a comprehensive literature search in PubMed, EMBASE and SCOPUS (up to October 25th 
2019) electronic databases to identify studies evaluating the role of prophylactic clipping in preventing post-
polypectomy bleeding. PROSPERO was searched for ongoing or recently completed systematic reviews. 
Electronic searches were supplemented by manual searches of references of included studies and review 
articles. 
We identified studies using the following medical subject headings (MeSH) and the keywords “clip”, 
“clipping”, “polypectomy”, “bleeding” and “endoscopic resection”. The search was restricted to English 
language.  
The Medline search strategy was: “(((((("surgical instruments"[MeSH Terms] OR ("surgical"[All Fields] 
AND "instruments"[All Fields]) OR "surgical instruments"[All Fields] OR "clip"[All Fields]) AND 
polypectomy[All Fields]) OR (("surgical instruments"[MeSH Terms] OR ("surgical"[All Fields] AND 
"instruments"[All Fields]) OR "surgical instruments"[All Fields] OR "clip"[All Fields]) AND endosopic[All 
Fields] AND resection[All Fields])) OR (("surgical instruments"[MeSH Terms] OR ("surgical"[All Fields] 
AND "instruments"[All Fields]) OR "surgical instruments"[All Fields] OR "clip"[All Fields]) AND 
("hemorrhage"[MeSH Terms] OR "hemorrhage"[All Fields] OR "bleeding"[All Fields]) AND ("prevention 
and control"[Subheading] OR ("prevention"[All Fields] AND "control"[All Fields]) OR "prevention and 
control"[All Fields] OR "prophylaxis"[All Fields]))) OR (clipping[All Fields] AND polypectomy[All 
Fields])) OR (clipping[All Fields] AND endosopic[All Fields] AND resection[All Fields])) OR (clipping[All 
Fields] AND ("hemorrhage"[MeSH Terms] OR "hemorrhage"[All Fields] OR "bleeding"[All Fields]) AND 
("prevention and control"[Subheading] OR ("preventio "[All Fields] AND "control"[All Fields]) OR 
"prevention and control"[All Fields] OR "prophylaxis"[All Fields]))” 
Selection process 
Two review authors (M.S.; R.M.) independently screened the titles and abstracts yielded by the search 
against the inclusion criteria. Full reports were obtained for all titles that appeared to meet the inclusion 
criteria or where there was any uncertainty. Review author pairs then screened the full text and abstrct 
reports and decided whether these met the inclusion criteria. Disagreements were resolved through 
discussion of all the authors. The reasons for excluding trials were recorded. Neither of the review authors 
was blinded to the journal titles or to the study authors or institutions. When there were multiple articles for a 
single study, we used the latest publication and supplemented it, if necessary, with data from the more 




Using standardized forms, two reviewers (M.S.; R.M.)  extracted data independently and in duplicate from 
each eligible study. Reviewers resolved disagreements by discussion. Unresolved disagreements were 
resolved by two arbitrators (C.H.; A.R.). The following data were extracted for each study including the 
publication status, the study design and location, the number of centers involved, the number of patients, 
patient characteristics (mean/median age, gender, anti-thrombotic therapies), the number of all lesion, the 
number of procedures, mean/median lesion size, lesion location (proximal, distal), lesion aspect and 
histology,  adverse events (bleedings, perforation surgery), mean/median lesion size. The corresponding 
authors of the included studies were asked for missing data. 
Quality assessment 
Quality was assessed by the Cochrane risk bias tool for randomized studies. Two reviewers (M.S., R.M.) 
assessed quality measures for included studies and discrepancies were adjudicated by collegial discussion. 
The overall quality of evidence was appraised by applying GRADE methodology1 for the primary outcomes  
Multilevel (random-effects) model: meta-analysis of rates of PPB with clipping in comparison to not-
clipping.  
The effect size of the meta-analysis was the transformed logit proportion of PPB. The current meta-analysis 
included studies reporting multiple effect sizes (one for each study arm). Multiple effects sizes within the 
same study may be correlated, violating the assumption of statistical independence. Thus, a multilevel m ta-
analytic model was employed, taking into account the potential clustering effects within studies. This 
approach adds random effects for each effect size wthin each study to the traditional random-effect model. 
Therefore, there are two random effects: the first random effect represents the variability between effect sizes 
assessed in the same study (i.e., between-outcomes r within-study variance), whereas the second random 
effect represents the variability among the effects ob erved in different studies (i.e., the between-study 
variance). For model fitting, we used the rma.mv function in metafor package in R package2.  
The random effects at the level of outcome and study were specified as a list of one-sided formulas in the 
random argument of the rma.mv function. The REML method was used and It was assumed a compound 
symmetry structure for the random effects (i.e., the correlation coefficient  for the correlation between the 
different outcomes was constant across studies). The model assumed independent sampling errors of effect 
size estimates. This is an appropriate assumption because there was no overlap in the patients used to 
compute outcome data in the two study arms. Subsequently, the multilevel model was extended by including 
predictor variables of delayed bleeding events (i.e., study arm, prevalence of large lesions and proximal 
colon location) in an attempt to find variables that moderate the effect. We also considered appropriate 
interactions between these variables. Data were present d as odds ratios (ORs) and 95% CIs. 
1. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, 
DeBeer H, Jaeschke R, Rind D, Meerpohl J, Dahm P, Schünemann HJ. GRADE guidelines: 1. 
Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011; 64: 
383–394. 
2. Viechtbauer, W. (2010). Conducting meta-analyses in R with the metafor package. Journal of 
Statistical Software, 36(3), 1-48. URL: http://www.jstatsoft.org/v36/i03/ 
 
  

























Albeniz (2019) Low Risk Low Risk High risk High risk Low Risk Low Risk Low Risk 
Dokoshi (2015) Unclear risk Low Risk High risk High risk Low Risk Low Risk Low Risk 
Feagins (2019) Low Risk Low Risk High risk High risk Low Risk Low Risk Low Risk 
Matsumoto 
(2016) 
Low Risk Unclear risk High risk High risk Low Risk Low Risk Low Risk 
Mori (2015) Low Risk Low Risk High risk High risk Low Risk Low Risk Low Risk 
Osada (2016) Unclear risk Low Risk High risk High risk Low Risk Low Risk Low Risk 
Pohl (2019) Low Risk Low Risk High risk High risk Low Risk Low Risk Low Risk 
Shioji (2003) Unclear risk Low Risk High risk High risk Low Risk Low Risk Low Risk 
Zhang (2015) Unclear risk Low Risk High risk High risk Low Risk Low Risk Low Risk 
 
  
Appendix 2, Supplemental Table 2 Meta-Analysis of by-polyp delayed post-polypectomy bleeding events 
and clips use: “Leave-One-Out” Sensitivity.  
 Influential analysis (Fixed effects model) Influential analysis Random effects model) 
 
RR 
 [95%-CI]  p-value tau2 I2 
RR  




[0.51; 1.00] 0.051 0.140 32.10% 
0.76 




[0.47; 0.90] 0.010 0.155 37.00% 
0.66  




[0.45; 0.91] 0.012 0.200 38.20% 
0.67  





[0.39; 0.803] 0.002 0.031 8.40% 
0.58  




[0.47; 0.89] 0.008 0.104 29.40% 
0.67 




[0.49; 0.92] 0.013 0.162 39.50% 
0.69  




[0.52; 1.11] 0.163 0.147 28.60% 
0.77  




[0.48; 0.91] 0.012 0.163 38.90% 
0.68  




[0.536; 1.03] 0.077 0.033 11.00% 
0.75 
 [0.52; 1.09] 0.137 0.032 10.92% 
Pooled estimate 
0.67 
 [0.49; 0.92] 0.013 0.126 31.10% 
0.69  




Appendix 2, Supplemental Table 3 Multilevel meta-regression analysis of PPB events.  
 Ors 95% CI  P-value 
Unclipped polyps (reference level) 1   
Clipped polyps 1.06 (0.66-1.75) 0.804 
Percentage of large lesions  
(as a continuous variable) 1.28 (1.16-1.42) <0.001 
Use of Clip x Percentage of large lesions 0.92 0.85-0.98 0.016 
Percentage of proximal lesions 
 (as a continuous variable) 0.86 (0.67-1.10) 0.223 
  
Appendix 2, Supplemental Table 4 - A multilevel random effect model with study arm, polyp lesion (large 
vs. small polyps), and their interaction term was fitted to the data. The two-way interaction term between 
polyp size and study arm was statistically significant. Results from the model shows a protective effect of 
clipping for large polyps (clipped large vs. unclipped large, OR, 0.54; 95% CI:0.30-0.97), while no 
protective effect of clipping was seen among small polyps (clipped small vs. unclipped small, OR:0.79; 95% 
CI:0.43-1.44; p=0.435).  
 Multilevel Meta-regression analysis 
 ORs 95% CI  P-value 
Clipped large vs. Unclipped large 
polyps 0.54 (0.30-0.97) 0.041 
Unclipped small polyps vs. 
Unclipped large polyps 0.22 (0.12-0.40) <0.001 
Clipped small vs. Unclipped small 
polyps 0.79 0.43-1.44 0.435 
Clipped small vs. Clipped large 
polyps 0.36 (0.19-0.66) <0.001 
 
  
Appendix 2, Supplemental Table 5 - A multilevel random effect model with study arm, proximal colon 
location and their interaction term was fitted to the data. The two-way interaction term between colon 
location and study arm was statistically significant (p=0.017). Results from the model shows a protectiv  
effect of clipping for proximal polyps (clipped proximal vs. unclipped proximal polyps, OR, 0.46; 95% 
CI:0.24-0.88), while no protective effect of clipping was seen among distal polyps (clipped distal vs. 
unclipped distal polyps, OR:1.21; 95% CI:0.56-2.62; p= 0.631). After adjusting for the prevalence of large 
lesions in the multilevel model, the benefit of clipping in reducing PPB was significant only for large 
proximal lesions (clipped versus unclipped polyps, OR, 0.34; 95% CI:0.19-0.65; p=0.021), but not for small 
proximal lesions (clipped versus unclipped polyps, OR, 0.88; 95% CI:0.48-1.62; p=0.581). 
 Multilevel Meta-regression analysis 
 ORs 95% CI  P-value 
clipped proximal  vs. unclipped 
proximal polyps 0.46 (0.24-0.88) .0018 
unclipped distal vs. unclipped 
proximal polyps 0.42 (0.24-0.73) <0.001 
clipped distal vs clipped proximal 
polyps 
1.09 (0.61-1.95) 0.764 
clipped distal vs. unclipped distal 
polyps 1.21 0.56-1.38 0.631 
 
  
Appendix 2, Supplemental Table 6. GRADE evidence profile for efficacy of clipping vs. no clipping 
strategy in reducing post procedural bleeding. 
* Risk of bias was judged as serious due to the low-moderate quality of the included randomized controlled 
trials. 
** Inconsistency risk was judged as serious due to heterogeneity among patients (i.e. different indications to 
resection in term of lesion size or location). 
 
  




















































































Appendix 2, Supplemental Table 7. Technical features. NA: Not available. 
 
Study Electrosurgical generators Clips 
Albeniz (2019) ERBE (ICC200, VIO 200 or 
VIO300); Endocut mode 
Micro-Tech, Nanjing, China 
Dokoshi (2015) ERBE (ICC200 or VIO300); 
Endocut mode 
HX-610-135, Olympus, Tokio, 
Japan 
Feagins (2019) NA NA 
Matsumoto (2016) ERBE (ICC200 or VIO200); 
Olympus (ESG-100, PSD.60) 
NA 
Mori (2015) ERBE (VIO300); Swift mode HX-610-135, Olympus, Tokio, 
Japan 
Osada (2016) ERBE (VIO300); Endocut mode ZEOCLIP ZP-CH ZeonMedical, 
Tokio, Japan 
Pohl (2019) ERBE generators; Endocut or 
forced coagulation modes  
Resolution clip, Boston Scientific, 
Marlborough, US 
Resolution 360 clip, Boston 
Scientific, Marlborough, US 
Shioji (2003) Olympus (UES-10); blended 
current. 
HX-5QR-1, Olympus, Tokio, Japan 
 
Zhang (2015) ERBE (ICC200 or VIO300); 
Endocut mode 
HX-610-135, Olympus, Tokio, 
Japan 
Resolution clip, Boston Scientific, 
Natic, US 
Appendix 3, Supplemental Figure 1: Meta-Analysis of PPB rates of delayed bleeding - a multilevel 
random effects model accounting for the underlying heterogeneity between and within trials was used to 








Appendix 3, Supplemental Figure 2: Funnel plot of publication bias – Ratio Risk of PPB (i.e., post-




Appendix 3, Supplemental Figure 3:  Meta-Analysis of relative risk of post-polypectomy bleeding (PPB) - 
results from per-protocol analysis (i.e., PPB after completion of clipping). The study by Matsumoto had 
substantial influence on the pooled effect size estimate.  
 
  
Appendix 3. Supplemental Figure 4 – The Figure shows a plot of the risk ratio estimate (d rived from the 
meta-regression model) as a function of the percentag  (decimal number) of large lesions. The estimated risk 
ratio of PPB associated with clip use was not significantly different from 1 for a prevalence of large lesions 
of 0% (only small lesions included, RR=1.06; 95% CI: 0.66-1.72), indicating an equal PPB risk on averag  
for small clipped and unclipped polyps. However, we found increasingly large effects as the prevalence of 
large lesions increases. The estimated risk ratios of PPB for clipped (versus unclipped) polyps were 0.69 




Appendix 3, Supplemental Figure 5: Meta-Analysis of PPB rates for large and small polys -a multilevel 
random effects model accounting for the underlying heterogeneity between and within trials was used to 
estimate the rates of PPB for large and small lesions with and without clips. In our dataset, 3 studies reported 
data on both large and small lesions, 3 studies only  large lesions and the remaining 3 studies only 
small lesions. Therefore, this analysis included 12 effect size estimates (6 for each study arm) of PPB among 





Appendix 3, Supplemental Figure 6: Meta-Analysis of relative risk of delayed bleeding - results from a 
sensitivity analysis among studies defining proximal lesions as sited proximally to the splenic flexure 
(including transverse colon). 
 
  
Appendix 3, Supplemental Figure 7: Meta-Analysis of relative risk of delayed bleeding - results from a 




Appendix 3, Supplemental Figure 8: Meta-Analysis of PPB rates of delayed bleeding in the proximal 
colon location - a multilevel random effects model accounting for the underlying heterogeneity between and 
within trials was used to estimate the rates of PPB for proximally and distally located lesions with and 
without clips. The analysis included 7 studies (n=6,63  polyps) with available count data for proximal 
(n=3268) and distal lesions (n= 3368). Therefore, 14 effect size estimates (7 for each study arm) of PPB 







Appendix 3, Supplemental Figure 9: Forest plot, showing the results from a cumulative meta-analysis of 
the relative risk of PPB for clipped and unclipped polyps in the proximal colon. The cumulative meta-
analysis was based on the study prevalence of largeesions and on a random-effect model. The analysis 
shows how the overall estimate changes as studies with increasing prevalence of large lesions are added to 
the pool. Each study was added to the next one, and the summary effect was calculated at each step. Results 
from the cumulative meta-analysis suggest that studies with large lesions may overestimate the effect of lip 
in lowering the risk of PPB in the proximal colon.  
 
Appendix 3, Supplementary Figure 10 - A) Forest plot, showing the results from a cumulative meta-
analysis of the relative risk of PPB for clipped and unclipped polyps in the distal colon. The cumulative 
meta-analysis was based on the study prevalence of large lesions (descending order) and on a random-effect 
model. Results from the cumulative meta-analysis suggested that the study by Polh may underestimate the 
protective effect of clip for large distal lesions. B) A sensitivity analysis excluding the study by Pohl. After 
excluding this study (in a sensitivity analysis), studies including large lesions demonstrated a significant 
negative association between clip use and risk of PPB in the distal colon, supporting the hypothesis of a 
protective effect of clip for large distal polyps (RR:0.28; 95% CI:0.08-0.97; p=0.044). However, when 
studies reporting on small lesions were successively added to the analysis, the magnitude of the treatm n  
effect began to increase and became non-significant. Note. Cum. #, cumulative number of cases.  
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What you need to know: 
Background and Context: It is not clear whether prophylactic clipping prevents bleeding after 
polypectomy. 
 
New Findings: A meta-analysis of randomized trials showed that routine use of prophylactic 
clipping does not reduce risk of post-polypectomy bleeding, overall. However, clipping appeared to 
reduce bleeding after removal of large (more than 20 mm) and proximal lesions. 
 
Limitations: This was a meta-analysis of previous studies. Further prospective studies are needed. 
 
Impact: Only large (more than 20 mm) and proximal colorectal lesions should be clipped to 
prevent bleeding after polypectomy. 
 
Lay Summary: This study showed the applying a clip prevents bleeding after removal of large 
polyps, in specific regions of the colon, but does not prevent bleeding of all polyps overall. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
